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Introduction
In 1988 Pickering et al. reported in the Lancet a series of 11 hyper-
tensive patients with bilateral atheromatous renovascular disease
who presented with a history of multiple episodes of pulmonary
oedema.1 Seven of these patients had stenosis of both renal
arteries and in a subsequent series of 90 patients, pulmonary
oedema was significantly more common in patients with bilateral
than in those with unilateral renal artery stenosis (RAS).2 Success-
ful revascularization of one or both renal arteries eliminated pul-
monary oedema in 77% of patients with bilateral RAS.2 The
authors concluded that ‘bilateral RAS may be a specific and treata-
ble predisposing factor to pulmonary oedema in azotemic hyper-
tensive patients’.1 Since the initial observation of this clinical
entity 29 case reports,3 –31 9 case series,1,32– 39 and 10 clinical
studies1– 2,40– 47 of flash pulmonary oedema (FPO) and RAS
(both unilateral and bilateral) have been published of which 16
case reports, 2 case series, and 7 clinical studies comprising a
total of 87 patients relate to bilateral RAS and FPO. The underlying
pathophysiological mechanisms responsible for triggering FPO in
patients with bilateral RAS have been delineated in several clinical
and experimental studies. Since FPO and bilateral RAS seem to be
a unique entity with distinct pathophysiological, clinical, and thera-
peutic features, we propose to name it Pickering Syndrome. In the
following, we review incidence, pathophysiology, clinical findings,
and treatment of the Pickering Syndrome.
Definition
Flash pulmonary oedema is a general term used to describe a par-
ticularly dramatic form of acute decompensated heart failure.
Regardless of its aetiology, an acute increase of left ventricular
(LV) end diastolic pressure is the conditio sine qua non for the
development of FPO and remains the common denominator of
all clinical situations associated with it. However, what distinguishes
FPO from other forms of decompensated heart failure is that
because of unique underlying pathophysiological mechanisms,
flooding of the alveolar space can occur within minutes resulting
in an acute life-threatening emergency.48
Prevalence
Atherosclerotic renal artery disease is increasingly diagnosed and
strongly associated with atherosclerotic disease in other vascular
beds such as the coronary, carotid, and iliofemoral circulation.49
Renovascular hypertension is the most common secondary cause
of hypertension. In 26 studies comprising a total patient population
of 30 092 undergoing diagnostic coronary angiography for sus-
pected coronary artery disease the prevalence of RAS .50% aver-
aged 8.0% with a range from 3.1 to 22.9% (Table 1).43,50–74 Of all
patients with atherosclerotic RAS, 20.3% had significant bilateral
RAS. The prevalence of FPO varies a great deal and seems to
depend on the pressure load as well as on the degree of renal
impairment. In a series of 56 patients with bilateral RAS, Bloch
et al.2 reported a history of FPO before revascularization in 23
(41%) patients. Messina et al.35 reported 17 patients with RAS
treated at the University of Michigan Hospital, 16 of who had bilat-
eral disease. Mean blood pressure was 207/110 mmHg and serum
creatinine was 3.5 mg/dL. Two-thirds of these patients had FPO
despite evidence of normal ventricular function. Overall the
weighted prevalence of FPO in patients with RAS was 15.3%. In
patients with bilateral RAS the weighted prevalence of FPO was
14.3% compared with 3.5% in those with unilateral RAS.
Pathophysiology
Bilateral RAS predisposes patients to develop FPO by three
main pathophysiological mechanisms: (i) defective natriuresis;
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(ii) increased haemodynamic burden and exacerbation of diastolic
dysfunction;75 and (iii) failure of the pulmonary capillary blood–gas
barrier (Figure 1).
Experimental studies allow us to clearly delineate differences in
pathophysiology between unilateral and bilateral RAS. In patients
with unilateral RAS corresponding to the 2-kidney-1-clip hyperten-
sion model, stenosis of one renal artery decrease ipsilateral renal
perfusion thereby activating the renin–angiotensin–aldosterone
cascade and causing sodium and fluid retention.76 Concomitantly,
stimulation of the sympathetic nervous system occurs, triggered
directly by renal ischaemia77 as well as by the activation of the
renin–angiotensin system.78 Since the contralateral kidney is func-
tioning normally, it compensates for the increase in blood pressure
by suppressing renin secretion and augmenting sodium excretion;
so-called pressure natriuresis occurs. However, this escape mech-
anism is defective in patients with bilateral RAS which corresponds
to the1-kidney-1-clip hypertension model. Since now perfusion to
both kidneys is hampered, pressure natriuresis cannot take place
and intravascular volume expansion secondary to sodium and
water retention persists.79 Indeed, Hall et al.80 experimentally
showed that high circulating angiotensin levels caused a marked
increase in blood pressure and sodium retention, rapidly resulting
in FPO when renal artery perfusion pressure was kept low, as is
the case with bilateral RAS. In contrast, no sodium retention was
observed when renal artery pressure was allowed to increase,
suggesting that this increase is seminal in helping the kidneys to
escape from the sodium retaining effect of angiotensin.
Sustained blood pressure elevation in patients with RAS may
give rise to left ventricular hypertrophy (LVH) most often of the
concentric type and to diastolic LV dysfunction.81 Concomitant
arterial stiffening increases pulse wave velocity so that the reflected
pulse wave returns during systole instead of during diastole82– 83
thereby further augmenting systolic ventricular pressure load.84
Normally, the LV compensates for an increase in afterload by
increasing end-diastolic volume (preload reserve). However, in
patients with a stiff LV, this safety mechanism is rapidly exhausted
and even small increases in LV end-diastolic volume may give rise
to a marked elevation in end-diastolic pressure, left atrial, and
pulmonary venous pressure.78 Moreover, in patients with diastolic
dysfunction and stiff LV, excessive sympathetic activation may also
precipitate the development of FPO. The tachycardia-induced
decrease of diastole duration further impairs the ability of the
stiff LV to fill and results in retrograde elevation of pulmonary
venous pressure. Hence, patients with LV and vascular stiffening
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Table 1 Prevalence of RAS >50% in patients undergoing cardiac catheterization
Study Year Number of patients Prevalence of RAS (%) Prevalence of bilateral RASa (%)
Alhaddad et al.50 2001 171 7.60 38.5
Aqel et al.51 2003 90 27.8 36
Buller et al.52 2004 851 14.1 —
Cohen et al.53 2005 843 18.3 —
Conlon et al.54 2001 3987 9.10 —
Crowley et al.55 1998 14 152 6.20 20.2
Dzielin´ska et al.56 2007 333 12.0 20
Ghaffari et al.43 2009 732 11.9 42.5
Harding et al.57 1992 1235 15.2 27.7
Jean et al.58 1994 196 18.4 —
Leandri et al.59 2004 467 9.00 31
Ollivier et al.60 2009 650 14.5 21.3
Ramirez et al.61 1987 102 4.90 —
Ravichandran et al.62 2003 614 8.47 9.6
Rigatelli et al.63 2005 205 19.5 37.5
Rihal et al.64 2002 297 19.2 19.3
Rimoldi et al.65 2010 1403 8.00 25
Saleh and Bustami66 2004 354 3.10 18.2
Sani et al.67 2008 260 14.2 —
Shen et al.68 2001 280 15.4 32.6
Song et al.69 2000 427 5.60 25
Tumelero et al.70 2005 1656 13.7 11
Vetrovec et al.71 1989 118 23 37
Wang et al.72 2003 203 14.8 16.7
Weber et al.73 2002 177 10.7 26.3
Yamashita et al.74 2002 289 7.3 14.3
Total 30 092 8.0 20.3
aPrevalence of bilateral RAS as % of all RAS patients. RAS, renal artery stenosis.
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Figure 1 The Pickering Syndrome. Three main pathophysiological mechanisms contribute to the development of flash pulmonary oedema:
defective pressure natriuresis with sodium and fluid retention, increased left ventricular end-diastolic pressure associated with left ventricular
hypertrophy and stiffening, and failure of the pulmonary capillary blood–gas barrier. RAAS, renin–angiotensin–aldosterone system; SNS, sym-
pathetic nervous system; Na+, sodium; AII, angiotensin II; ET-1, endothelin-1; NO, nitric oxide.
Figure 2 Key predisposing (left ventricular diastolic dysfunction, increased arterial stiffness, bilateral renal artery stenosis) and precipitating
(acute increase in blood pressure and/or intravascular volume, acute myocardial ischaemia) factors of the Pickering Syndrome. RAS, renal artery
stenosis. LVEDP, left ventricular end-diastolic pressure.
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have an exaggerated response to changes in intravascular volume
and sympathetic activity.85 Furthermore, the increased systemic
vascular resistance secondary to activation of renin angiotensin
aldosterone cascade and sympathetic nervous system increases
LV wall stress and causes a mismatch between increased oxygen
demand and delivery to the myocardium. This, in turn, aggravates
LV diastolic dysfunction resulting in a further increase in LV end-
diastolic pressure (Figure 1).
Pulmonary capillary stress failure and increased pulmonary vascu-
lar permeability are important but often overlooked pathogenetic
mechanism of FPO.48 The rapid and exaggerated increase in LV
pressure transmits to left atrium, pulmonary veins and to the unpro-
tected pulmonary capillaries. Once intracapillary pressure exceeds
20–25 mmHg the oedema fluid leaks through the endothelial
barrier and floods the interstitial and, subsequently, alveolar
space.48 Excessive plasma and tissue levels of neurohumoral
mediators, such as angiotensin II, catecholamines, and endothelin-1,
may increase permeability of the alveolo-capillary barrier.48
In the case of decompensated bilateral RAS all of the
above-mentioned predisposing factors reunite and overcome the
protective mechanisms against alveolar fluid accumulation. In this
precarious situation even small fluctuations in blood pressure,
intravascular volume or renal perfusion and/or myocardial ischae-
mia may act as precipitating factors that can trigger FPO
(Figure 2).48 Once FPO ensues, LV pump function is prone to
decline which, in turn, will further hamper perfusion of the
kidneys, thereby giving rise to a vicious circle.
Clinical findings
The Pickering Syndrome can present a diagnostic conundrum and
the clinical findings of bilateral RAS must be differentiated from
unilateral RAS (Table 2). In the series described by Pickering,
FPO occurred on average 2.3 times before a diagnosis of RAS
was established. In our literature review of 87 patients with the
Pickering Syndrome mean age was 63 years, 47% were male and
73% were smokers. Of these patients 58% had coronary artery
disease and 40% had heart failure diagnosed in the past. Average
ejection fraction was 49% and 50% had LVH. Renal failure was
evident in 94% of patients and the mean creatinine was 3.8 mg/
dL (336 mmol/L). As to FPO, only 7% had a single episode of
FPO before the diagnosis and 93% had recurrent episodes of
FPO. Classically, patients present with sudden onset of severe,
unprovoked dyspnoea (‘flash’ pulmonary oedema) although the
LV systolic function is usually normal. The occasional presence of
coronary artery disease may result in misinterpretation of FPO
as being caused by coronary ischaemia. However, in many patients,
coronary angiography reveals no flow limiting stenosis. This finding
coupled with normal LV systolic function can lead to a false sense
of security or give rise to evaluation for non-cardiac causes for dys-
pnoea. The frequent nocturnal appearance of FPO may be due to
reverse nocturnal dipping which has been well documented in
patients with RAS.86,87
Therapy
The therapeutic approach to the Pickering Syndrome can be
divided into two distinct phases.
Phase 1 is characterized by the occurrence of FPO which rep-
resents a hypertensive emergency requiring immediate therapeutic
intervention. Haemodynamic unloading by antihypertensive drugs
usually result in prompt resolution of FPO but may further compro-
mise renal blood flow and function. This is particularly true with
inhibitors of the renin–angiotensin–aldosterone system. Although
empirically, renin–angiotensin–system inhibitors should prove to
be very useful for emergency treatment of FPO, they may precipitate
acute renal failure and their continued use becomes relatively contra-
indicated once the patient has been stabilized. In the acute phase, a
loop diuretic should be added to initiate natriuresis and overcome
sodium retention. Of note, there is no iron clad evidence to
exactly guide us, how to optimally proceed in a patient presenting
with the acute phase of the Pickering Syndrome. In Phase 2, once
the patient is out of pulmonary oedema and has been stabilized,
renal revascularization is the treatment of choice, since the pathophy-
siology of the Pickering Syndrome is characterized by the inability to
generate a pressure natriuresis due to renal hypoperfusion.2,47 Both
surgical and percutaneous revascularization techniques have been
successful in treating RAS and its clinical manifestations such as
FPO (Table 3).1–2,32,35–36,38,44–45,88–90 Renal revascularization
decreases circulating angiotensin and aldosterone levels resulting in
a fall in blood pressure, and since revascularization improves renal
perfusion, in an increase in glomerular filtration rate and natriuresis.
Renal artery surgery is an effective method for revascularization
but is associated with greater morbidity and mortality than percu-
taneous endovascular techniques. The ACC/AHA guidelines
endorse percutaneous revascularization as a class I recommen-
dation for patients with haemodynamically significant RAS and
recurrent, unexplained congestive heart failure, or pulmonary
oedema.91 The efficacy of successful renal artery revascularization
in resolving FPO can be dramatic (Table 3). Evidence is compelling
that stenting is superior over balloon angioplasty.91– 93 This is par-
ticularly true for atherosclerotic aorta-ostial RAS.94– 96 In patients
with severe/acute heart failure and combined renovascular and
coronary artery disease, renal revascularization with stents
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Differences in clinical findings before
unilateral and bilateral renal artery stenosis
Renal artery stenosis
Unilateral Bilateral
RAAS activation  
Na/Fluid volume state Pressure
natriuresis
Sodium
retention
Cardiac output Normal 
Total peripheral resistance  
BP response to RAS blockade  
Flash pulmonary oedema Rare Common
Natriuresis post angioplasty
of RAS
No Yes
BP, blood pressure; RAAS, renin–angiotensin–aldosterone system; RAS, renal
artery stenosis.
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achieves similar outcomes and improved functional status indepen-
dent of coronary revascularization.47 A recent cohort-controlled
study demonstrated a significant benefit for renal stent revascular-
ization compared with continued medical therapy in 50 patients
presenting with heart failure who had bilateral RAS or RAS and
a solitary kidney being treated for uncontrolled hypertension or
ischaemic nephropathy.89 Patients who received renal stents
improved their New York Heart Association Functional Class
(1.9+ 0.8 vs. 2.6+ 1.0, P, 0.04) compared with those treated
conservatively. Although there was no mortality benefit, there
was a significant reduction in recurrent heart failure events and
the need for rehospitalization was reduced five-fold in the renal
stent group. Renal stenting has a remarkably low failure rate with
primary patency rates of 79–84% and secondary patency rates
of 92–98% after 5 years of follow-up.97,98
In our literature review of 87 reported cases of bilateral RAS
and FPO, 35% were treated with unilateral and 22% with bilateral
angioplasty. In 43% of patients, mostly in earlier reports, surgical
revascularization was performed. Stenting was unsuccessful in
two patients, one of whom improved with carvedilol and the
other after resuming ACE-Inhibitor therapy. Renal function
improved in 81% of patients and the mean creatinine on follow-up
was 1.6 mg/dL (141 mmol/L) after the procedure. Renal function
was normal at baseline and after angioplasty in two patients only.
Importantly, in 92% of all patients there was no further episode
of FPO after revascularization.
The acute phase the Pickering Syndrome can be treated effectively
by haemodynamic unloading and diuresis. In the subacute phase renal
stenting is treatment of choice. However, long-term prognosis in
patients with bilateral RAS remains guarded. Conlon et al.54 reported
a 4-year survival rate of ,50% in a series of 33 patients.
Comments
The Pickering Syndrome must be considered a unique pebble in
the mosaic of the so-called cardiorenal syndrome, a pathophysio-
logical condition in which impairment of cardiac and renal function
mutually accelerates each other. However, in contrast to the
cardiorenal syndrome which is ill defined and has a somewhat neb-
ulous pathophysiology, the Pickering Syndrome is clearly defined
and its pathophysiological mechanisms have been precisely deli-
neated. As such it is prone to serve as an illuminating teaching
model shedding light on one straight forward aspect of the
complex interaction between heart and kidney. This brings us
back to Thomas Pickering who dedicated his career in cardiovascu-
lar medicine to research, teaching, and patient care. His original
paper in Lancet1 is a prime example of keen observation and
crystal clear thinking attesting to his preeminence as an astute
teacher and clinician.
A personal memoir
Tom Pickering was one of my first D.Phil students in Oxford in the
late 1960s, following Harley Smyth in the early studies of the car-
diovascular effects of sleep in man. He was quietly modest, but an
outstandingly able and intelligent person, a pleasure to work
with—even during the middle of the night! His Oxford thesis on
‘Baroreceptor reflexes in man in health and disease’ was published
in 1970 and resulted in a series of publications in high-impact jour-
nals. I tried hard to get him to stay in Oxford, but could understand
his wish not to stay there—where his famous father was Regius
Professor of Medicine. He made his name in New York with
seminal work describing the psychological influences on cardiovas-
cular disease, with thoroughly controlled studies of the effects of
different kinds of job stress on blood pressure. The importance
of psycho-social influences on cardiovascular disease is now well
recognized and has become academically respectable—in large
part due his work. I was immensely impressed with the way
Tom managed himself when knowing he had limited time left. Sup-
ported bravely by his wife Janet, he came to several European
meetings in his final year, giving papers and joining discussions as
if nothing was amiss (P.S.).
Conflict of interest: none declared.
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